跳至主要内容
临床试验/JPRN-UMIN000034972
JPRN-UMIN000034972已完成未知

A retrospective cohort study to investigate the incidence of cachexia in pancreatic cancer patients - A retrospective cohort study to investigate the incidence of cachexia in pancreatic cancer patients

ONO PHARMACEUTICAL CO., LTD.0 个研究点目标入组 150 人开始时间: 2018年11月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

A total of 150 patients were registered. Base cachexia occurred in 50% of patients. Follow-up cachexia occurred in 32% within 12 weeks of starting first-line chemotherapy, reaching 64% at 1 year. Overall survival was not significantly different between patients with and without follow-up cachexia. Appetite loss, fatigue, nausea, and diarrhea were more frequent in patients with follow-up cachexia than in those without follow-up cachexia.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who meet at least one of the following exclusion criteria are not included. 1) Patient who underwent surgical operation of the gastrointestinal tract within the last 6 months starting from the beginning day of the first systemic chemotherapy excluding stent placement in the duodenum or gastrojejunostomy 2) Patients with simultaneously active, double cancer (Stage I intraepithelial carcinoma, intramucosal carcinoma, superficial bladder carcinoma, or other cancers without recurrence for 5 years or more can be registered) 3) Patients with missing of body weight data over 12 weeks in the medical consultation period after the beginning of initial systemic chemotherapy 4) Patients who underwent puncture for ascitic fluid at the beginning of initial systemic chemotherapy

研究者

发起方
ONO PHARMACEUTICAL CO., LTD.

相似试验

A retrospective cohort study to investigate the... | 临床试验